Studies have shown that over 80% of the population will suffer from lower back pain at some point in their lives.
Vancouver, BC (PRWEB) May 28, 2013
According to a series of reports published this year by iData Research, the U.S. total spinal implant market was worth over $5.5 billion, with the minimally invasive surgery (MIS) spinal implant market comprising $1.5 billion of that value. MIS spinal implants include spinous process fixation, facet fixation, MIS interbody fusion, pedicle screws, spine endoscopes, and sacroiliac joint fusion, the fastest growing segment. Throughout the last few years, the MIS spinal surgery market has grown at a high rate as MIS techniques have become more popular. This market is expected to maintain double-digit growth rates in the future.
The fastest growing population segment in the U.S. has comprised those over the age of 65. Since the majority of spinal fusions are performed to treat degenerative diseases that are often associated with age, the growing elderly population will cause an increase in the number of annual fusion procedures performed. Studies have shown that over 80% of the population will suffer from lower back pain at some point in their lives. A majority of these cases can be attributed to two main causes: general factors such as muscle strain, injury and overuse; and specific spine conditions such as herniated discs, degenerative disc disease, spondylolisthesis or spinal stenosis. Sacroiliac (SI) joint dysfunction was once thought to be a less common cause for lower back pain. However, recent studies have shown that SI joint dysfunction (SIJD) may be responsible for up to 25% of lower back pain cases.
With the notion that up to a quarter of lower back pain incidents can be attributed to the SI joint, there was an inherent need for an effective and efficient treatment for SIJD. “The call was answered with the introduction SI-BONE’s iFuse Implant System® (iFuse®),” explains Dr. Kamran Zamanian, CEO of iData, “the first minimally invasive system on the market geared towards SI fusion.” SI-BONE received FDA approval to market its iFuse® implants in November 2008. Since its commercial release, the system has contributed to a significant growth in the U.S. SI fusion market. In the last couple of years, Zyga Technology received its 510(k) clearance for the SImmetry™, Globus Medical received 510(k) for the SI-LOK® implant, and SIGNUS Medical is expected to enter the market with the DIALOG™ (or DIANA™ as it is known in European markets). The emergence of additional competitor products will continue to drive growth in this market as awareness of the procedures becomes increasingly rampant though the marketing efforts of these companies.
Medtronic is currently the market leader in the total and MIS spinal implant device markets mostly due to its lead in the thoracolumbar and cervical fixation, and interbody fusion segments, as well as their minimally invasive interbody fusion and pedicle screw markets with their MAST and CD Horizon® portfolios of MIS products. Medtronic’s share in each of these segments collectively put the company at the forefront of the market. Other competitors reported by iData that command significant shares in the spinal implant market include DePuy Synthes, Stryker, Zimmer, and Globus Medical, all of which compete directly with Medtronic in a number of spinal implant segments.
A free synopsis for every report in the global series on the Markets for Spinal Implant Devices covering the U.S., 15 counties in Europe, Brazil, Argentina, Mexico, Japan, India, China, and Taiwan is available here(Spinal Implants) and here (Spinal MIS). The complete reports provide a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players’ success strategies in each segment and sub-segment. The reports cover markets for: MIS interbody fusion, pedicle screws and sacroiliac joint fusion, as well as spinal endoscopes, facet fixation, cervical and thoracolumbar fixation, motion preservation, vertebral compression, and spinal electrical stimulation.
About iData Research
iData Research is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: orthopedic biomaterials, orthopedic trauma, large and small joints, orthopedic soft tissue, and spine and MIS.